Weiwei Tao

机构：The University of Texas MD Anderson Cancer Center, Wenzhou Medical University, Progenics Pharmaceuticals (United States), Zhejiang Taizhou Hospital

发表论文 42 篇 · 总被引 1283 次 · h-index 16

代表论文

• Turning main-group element magnesium into a highly active electrocatalyst for oxygen reduction reaction (2020 · Nature Communications · 被引 413)
• Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer (2021 · Journal for ImmunoTherapy of Cancer · 被引 53)
• Microenvironmental Variations After Blood-Brain Barrier Breakdown in Traumatic Brain Injury (2021 · Frontiers in Molecular Neuroscience · 被引 47)
• Boosting oxygen evolution reaction on graphene through engineering electronic structure (2020 · Carbon · 被引 36)
• Review for metamaterials and metasurfaces based on vanadium dioxide phase change materials (2024 · Optics & Laser Technology · 被引 29)
• Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma (2024 · Journal of Cancer · 被引 23)